0001567619-20-011853.txt : 20200608
0001567619-20-011853.hdr.sgml : 20200608
20200608170129
ACCESSION NUMBER: 0001567619-20-011853
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
EFFECTIVENESS DATE: 20200608
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecule Ventures LP
CENTRAL INDEX KEY: 0001812786
IRS NUMBER: 850631351
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-368496
FILM NUMBER: 20949728
BUSINESS ADDRESS:
STREET 1: 250 WEST 55TH STREET
STREET 2: FL 35
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 905-0197
MAIL ADDRESS:
STREET 1: 250 WEST 55TH STREET
STREET 2: FL 35
CITY: NEW YORK
STATE: NY
ZIP: 10019
D
1
primary_doc.xml
X0708
D
LIVE
0001812786
Molecule Ventures LP
250 WEST 55TH STREET
FL 35
NEW YORK
NY
NEW YORK
10019
(212) 905-0197
DELAWARE
None
None
Limited Partnership
true
2020
Nicholas
Kracov
255 West 55th Street
FL 35
New York
NY
NEW YORK
10019
Director
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C.1
false
2020-06-01
true
true
false
100000
Indefinite
6100000
Indefinite
false
3
0
0
0
false
Molecule Ventures LP
/s/ Nicholas Kracov
Nicholas Kracov
Director of Molecule Ventures LLC, General Partner
2020-06-08